Pitcairn Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Pitcairn Wealth Advisors's BMY Position: Q2 2026 in Review
Pitcairn Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 57% in Q2 2026, buying an estimated $307K and bringing the position to 14,740 shares worth $849K. The position accounts for 0.09% of the portfolio, ranked #120.
Pitcairn Wealth Advisors first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Pitcairn Wealth Advisors held 14,740 shares of Bristol-Myers Squibb worth $849K as of Q2 2026.
- Pitcairn Wealth Advisors bought 5,355 Bristol-Myers Squibb shares in Q2 2026, an estimated $307K.
- Bristol-Myers Squibb made up 0.09% of Pitcairn Wealth Advisors's portfolio in Q2 2026, its #120 holding.
- Pitcairn Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Pitcairn Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.